Search
for
Sort by
Research 841–870 of 1000+
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- MiR-199a-3p Regulates the PTPRF/β-Catenin Axis in Hair Follicle Development: Insights into the Pathogenic Mechanism of Alopecia Areata
- Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Novel potential therapeutic targets of alopecia areata
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- A Retrospective Study on Alopecia Areata in Children: Clinical Characteristics and Treatment Choices
- New Modalities in the Treatment of Refractory Alopecia Areata
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Manifestaciones dermatológicas asociadas a la gravedad de la infección por COVID-19. Estudio observacional transversal retrospectivo de 144 pacientes
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab Emirates
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching